Antiplatelet agents: effects on the progressive renal disease.
Zoja
C
C
Mario Negri Institute for Pharmacological Research, Ospedali Riuniti di Bergamo, Italy.
Perico
N
N
Remuzzi
G
G
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D001792:Blood Platelets / Q000502:physiology; D006801:Humans; D007668:Kidney / Q000473:pathology / Q000503:physiopathology; D007674:Kidney Diseases / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013928:Thromboxane A2 / Q000037:antagonists & inhibitors; D013988:Ticlopidine / Q000494:pharmacology
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D013928:Thromboxane A2; D013988:Ticlopidine